Related Experiment Video
Updated: Mar 10, 2026
07:46
CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
6.6K
Targeted genome engineering in Caenorhabditis elegans
Xiangyang Chen1, Xuezhu Feng1, Shouhong Guang1
1School of Life Sciences, CAS Center for Excellence in Molecular Cell Science, University of Science and Technology of China, Hefei, Anhui 230027 People's Republic of China.
Cell & Bioscience
|December 17, 2016
Summary
This review covers genome editing in C. elegans, detailing methods like CRISPR/Cas9 for precise genetic modification in biomedical research.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Developmental Biology
Background:
- Genome modification is crucial for biomedical research, particularly in model organisms like Caenorhabditis elegans.
- Traditional methods include random mutagenesis and DNA integration via bombardment or irradiation.
- Recent advancements focus on precise gene manipulation using engineered nucleases.
Approach:
- This review summarizes site-specific genome editing techniques in C. elegans.
- It covers established methods such as Cre/LoxP, FLP/FRT, and MosTIC systems.
- The discussion emphasizes engineered nucleases: zinc-finger nucleases (ZFNs), TALENs, and CRISPR/Cas9.
Key Points:
- Site-specific genome editing offers enhanced precision and efficiency over random methods.
- CRISPR/Cas9 technology has emerged as a powerful and versatile tool for C. elegans genome engineering.
- Streamlined strategies are continually being developed to simplify experimental procedures and reduce costs.
Conclusions:
- The review highlights the significant progress in site-specific genome editing in C. elegans.
- CRISPR/Cas9 is poised to further revolutionize genetic research in this model organism.
- These advanced techniques accelerate the pace of discovery in C. elegans-based research.
